Health Insurance Lifetime Limits Lifted

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

December 31st 2024

Study Advocates Immunological Value of COVID Vaccination in MM

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

Listen

mRNA vaccines can boost T cell responses | image credit: myskin - stock.adobe.com

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA vaccines could bolster immunity in this vulnerable population.

December 26th 2024

Medical Loss Ratio’s Role in the Large Group Insurer Market

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Listen

Limited Benefits of ctDNA Testing in Colorectal Cancer Surveillance, Study Finds

The authors used medical loss ratio forms to assess trends in premiums, medical claims, administrative costs, quality improvement, and margins in the large group insurer market.

Colorectal cancer | Image credit: mi_viri - stock.adobe.com

Vitiligo Linked to Higher Cardiovascular Disease Risk

Adding serial circulating tumor DNA (ctDNA) assays to standard of care imaging surveillance had limited clinical benefits in patients with resected colorectal cancer (CRC).

Related Content

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

December 31st 2024

Study Advocates Immunological Value of COVID Vaccination in MM

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

Listen

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA vaccines could bolster immunity in this vulnerable population.

December 26th 2024

Medical Loss Ratio’s Role in the Large Group Insurer Market

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Listen

Limited Benefits of ctDNA Testing in Colorectal Cancer Surveillance, Study Finds

The authors used medical loss ratio forms to assess trends in premiums, medical claims, administrative costs, quality improvement, and margins in the large group insurer market.